4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001780662-25-000002
Chief Financial Officer sold 238 shares at $14.05 ($3,344)
From the SEC's structured data for this filing
Trades in this filing
PISKEL KYLE · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-17 | Sale : show line 1 in the form | −238 | $14.05 | $3,344 | 269,343 | D |
| Open-market sales · 238 sh · avg $14.05 · $3,344 | ||||||
Loading xslF345X05/primary_doc.xml…